Table 3.
Metabolic variablesa | N | Spearman correlation coefficient | 95% confidence limits | P valueb | |
---|---|---|---|---|---|
Index60 | 194 | -0.562 | -0.651 | -0.457 | < 0.0001 |
C-peptide Index | 194 | 0.544 | 0.437 | 0.636 | < 0.0001 |
C-peptide 30-0 min | 194 | 0.534 | 0.425 | 0.627 | < 0.0001 |
C-Peptide AUC | 194 | 0.484 | 0.368 | 0.585 | < 0.0001 |
Sum of C-peptide | 194 | 0.466 | 0.348 | 0.569 | < 0.0001 |
Peak of C-peptide | 194 | 0.436 | 0.315 | 0.544 | < 0.0001 |
Fasting C-peptide | 194 | 0.369 | 0.241 | 0.485 | < 0.0001 |
Sum of glucose | 194 | -0.341 | -0.460 | -0.210 | < 0.0001 |
Fasting glucose | 194 | 0.030 | -0.111 | 0.170 | 0.6758 |
Abbreviations: AUC, area under the curve; DPT-1, Diabetes Prevention Trial-Type 1 Diabetes; FPIR, first-phase insulin response; OGTT, oral glucose tolerance test; T1D, type 1 diabetes.
a Insulinogenic index and oral disposition index could not be calculated in DPT-1 because samples for insulin testing were not collected during OGTTs.
b Adjusted P values using the Benjamini-Hochberg method to control for false-discovery rates.